Male Tolerance Study of Dapivirine Gel Following Multiple Topical Penile Exposures

NCT01277640 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Topical Penile Exposures

Interventions

DRUG: dapivirine
DRUG: matched placebo
DRUG: universal placebo

Sponsor

International Partnership for Microbicides, Inc.